About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Zileuton and Exhaled Nitric Oxide in Asthmatics

NCT00575861·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Gelb, Arthur F., M.D.

Age

21–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Non-smoking
Moderate to severe persistent asthmatics
Clinically stable X 6 weeks on Advair 250/50 bid for at least 12 months

You may not be if

No leukotriene synthesis inhibitors or receptor antagonists for 6 weeks

The record

StatusCompleted

PhasePhase 4

Taking part19

StartedSep 2005

UpdatedDec 20, 2007

Conditions

Where1

Arthur F Gelb Medical Corporation
Lakewood, California, United States

Clareo Health | Zileuton and Exhaled Nitric Oxide in Asthmatics